Literature DB >> 23072275

Experimental human endotoxemia: a model of the systemic inflammatory response syndrome?

Steve E Calvano1, Susette M Coyle.   

Abstract

BACKGROUND: The normal human intravenous endotoxin model has been used for more than 50 years. It was once considered a possible model of sepsis, but, because no infection is present, it is better described as a model of systemic inflammation. We demonstrate herein that at least three of four systemic inflammatory response syndrome (SIRS) criteria are achieved with the model.
METHODS: Otherwise healthy human volunteers were given Escherichia coli endotoxin 2 ng/kg intravenously. Vital signs were monitored, and blood samples were collected over time for assessment of white blood cells (WBCs), cytokines, counter-regulatory hormones, and monocyte receptors.
RESULTS: The means of three variables (core temperature, heart rate, WBC) met the SIRS criteria. Compared with baseline, cytokines were elevated acutely, with tumor necrosis factor-alpha (TNFα) exhibiting temporal primacy over the other cytokines. Counter-regulatory hormones (cortisol, epinephrine) also were elevated acutely. Finally, the monocyte cell-surface receptors cluster of differentiation molecule (CD) 11b and TNF receptor-II were elevated and decreased, respectively.
CONCLUSIONS: The experimental human endotoxin model satisfies SIRS criteria and probably is best described as a model of Toll-like receptor 4 agonist-induced systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23072275      PMCID: PMC3503465          DOI: 10.1089/sur.2012.155

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  54 in total

1.  Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans.

Authors:  A F Suffredini; J H Shelhamer; R D Neumann; M Brenner; R J Baltaro; J E Parrillo
Journal:  Am Rev Respir Dis       Date:  1992-06

Review 2.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

3.  Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; A Barber; W He; L L Moldawer; E D Bushman; S M Coyle; G T Shires; S F Lowry
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

4.  IL-8 in septic shock, endotoxemia, and after IL-1 administration.

Authors:  K J Van Zee; L E DeForge; E Fischer; M A Marano; J S Kenney; D G Remick; S F Lowry; L L Moldawer
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

Review 5.  Gout therapeutics: new drugs for an old disease.

Authors:  Christopher M Burns; Robert L Wortmann
Journal:  Lancet       Date:  2010-08-16       Impact factor: 79.321

6.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; L L Moldawer; H Wei; S E Calvano; J S Kenney; A C Allison; A Cerami; G T Shires; S F Lowry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial.

Authors:  Badar U Jan; Susette M Coyle; Leo O Oikawa; Shou-En Lu; Steve E Calvano; Paul M Lehrer; Stephen F Lowry
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

Review 8.  Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.

Authors:  Veruscka Leso; Lorenzo Leggio; Alessandro Armuzzi; Giovanni Gasbarrini; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 2.566

9.  Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction.

Authors:  Sonia M Alvarez; Maria Katsamanis Karavidas; Susette M Coyle; Shou-En Lu; Marie Macor; Leo O Oikawa; Paul M Lehrer; Steve E Calvano; Stephen F Lowry
Journal:  J Endotoxin Res       Date:  2007

10.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.

Authors:  G D Martich; R L Danner; M Ceska; A F Suffredini
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  25 in total

1.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

2.  The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice.

Authors:  Logan B Smith; Michael C Leo; Caroline Anderson; Teresa J Wright; Kristianna B Weymann; Lisa J Wood
Journal:  Brain Behav Immun       Date:  2014-01-08       Impact factor: 7.217

Review 3.  Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases.

Authors:  Parth N Patel; Rhia Y Shah; Jane F Ferguson; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-30       Impact factor: 8.311

4.  Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.

Authors:  Julie Lasselin; Michael T Treadway; Tamara E Lacourt; Anne Soop; Mats J Olsson; Bianka Karshikoff; Sofie Paues-Göranson; John Axelsson; Robert Dantzer; Mats Lekander
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

5.  Cellular metabolic regulators: novel indicators of low-grade inflammation in humans.

Authors:  Beatrice Haimovich; Zhiyong Zhang; Jacqueline E Calvano; Steve E Calvano; Ashwini Kumar; Marie A Macor; Siobhan Corbett; Susette M Coyle; Stephen F Lowry
Journal:  Ann Surg       Date:  2014-05       Impact factor: 12.969

6.  Temporal metabolic profiling of plasma during endotoxemia in humans.

Authors:  Kubra Kamisoglu; Kirsten E Sleight; Steve E Calvano; Susette M Coyle; Siobhan A Corbett; Ioannis P Androulakis
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

7.  Tissue-Specific Differential Expression of Novel Genes and Long Intergenic Noncoding RNAs in Humans With Extreme Response to Evoked Endotoxemia.

Authors:  Jane F Ferguson; Chenyi Xue; Yuanfeng Gao; Tian Tian; Jianting Shi; Xuan Zhang; Ying Wang; Yuhuang D Li; Zhi Wei; Mingyao Li; Hanrui Zhang; Muredach P Reilly
Journal:  Circ Genom Precis Med       Date:  2018-11

8.  Changes of Lipopolysaccharide-Induced Acute Kidney and Liver Injuries in Rats Based on Metabolomics Analysis.

Authors:  Huan Gao; Tao Yang; Xuan Chen; Yanqing Song
Journal:  J Inflamm Res       Date:  2021-05-06

Review 9.  A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.

Authors:  Janette Hope
Journal:  ScientificWorldJournal       Date:  2013-04-18

10.  E. coli endotoxin modulates the expression of Sirtuin proteins in PBMC in humans.

Authors:  Angela Storka; Gerhard Führlinger; Martin Seper; Lisa Wang; Michael Jew; Asha Leisser; Michael Wolzt
Journal:  Mediators Inflamm       Date:  2013-11-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.